GoodRx (NASDAQ:GDRX) Upgraded by Zacks Investment Research to Hold

GoodRx stock has undergone multiple analysts rating changes in the recent past.  GoodRx Upgraded by Zacks Investment Research on 10/12/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

Shares of GoodRx traded down -$0.31 on Tuesday, reaching $40.63. 105 shares of the stock traded hands, compared to its average volume of 1733511. Shares of GoodRx were trading at $40.63 on Tuesday. The firm’s 50 day moving average is $39.13 and its 200 day moving average is $39.47.GoodRx has a 12 month low of $40.14 and a 12 month high of $59.67. While on yearly highs and lows, GoodRx’s today has traded high as $41.52 and has touched $40.14 on the downward trend. See More Analyst Rating at: RATING

GoodRx Earnings and What to expect: 

GoodRx last announced its earnings results on August 12th, 2021. The reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.07. The company earned $176.64 million during the quarter, compared to analyst estimates of $174.15 million. GoodRx has generated ($0.96) earnings per share over the last year (($0.88) diluted earnings per share). Earnings for GoodRx are expected to grow by 600.00% in the coming year, from $0.04 to $0.28 per share. GoodRx has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, November 11th, 2021 based off prior year’s report dates.

Earnings for GoodRx are expected to grow by 600.00% in the coming year, from $0.04 to $0.28 per share. The P/E ratio of GoodRx is -46.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of GoodRx is -46.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. GoodRx has a PEG Ratio of 34.75. PEG Ratios above 1 indicate that a company could be overvalued. GoodRx has a P/B Ratio of 22.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

GoodRx (NASDAQ:GDRX) Moving Average Technical Analysis

5 day Moving Average is $41.45 And 5 day price change is -$2.49 (-5.77%)  with average volume for 5 day average is 1,086,940. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $43.28 and 20 day price change is -$3.98 (-8.92%) and average 20 day moving volume is 1,609,985. 50 day moving average is $39.13  and 50 day price change is $8.77 ( 27.53%)  and with average volume for 50 days is : 1,751,750. 200 day moving average is $39.47  and 200 day price change is -$5.69 (-12.28%)  and with average volume for 200 days is : 1,959,818.

Other owners latest trading in GoodRx :

  • On 10/8/2021 shares held by Creative Financial Designs Inc. ADV were 1,350 which equates to market value of $55K and appx 0.00% owners of GoodRx
  • On 10/6/2021 shares held by First Dallas Securities Inc. were 23,950 which equates to market value of $0.98M and appx 0.70% owners of GoodRx
  • On 10/6/2021 shares held by Hodges Capital Management Inc. were 117,466 which equates to market value of $4.82M and appx 0.40% owners of GoodRx
  • In total Institutional ownership equates to Institutional Ownership Percentage: 35.86% for GoodRx

See More Analyst Rating at: RATING